Table 1.
Subgroup | Clinical Presentation | |||
---|---|---|---|---|
Disappearance of Perifocal Oedema, Day | Full Wound Cleansing, Day | Appearance of Granulation, Day | Start of Edge Epithelialisation, Day | |
Placebo | 7.25 ± 0.25 | 8.25 ± 0.25 | 9.00 ± 0.00 | 9.50 ± 0.29 |
Resveratrol | 5.25 ± 0.25 * | 6.25 ± 0.25 * | 6.75 ± 0.25 * | 7.50 ± 0.29 * |
Dihydroquercetin | 5.50 ± 0.29 * | 6.75 ± 0.25 * | 7.00 ± 0.00 * | 7.50 ± 0.29 * |
Dihydromyricetin | 5.50 ± 0.29 * | 6.50 ± 0.29 * | 7.25 ± 0.25 * | 7.75 ± 0.25 * |
*—p < 0.05 if compared to the placebo group.